Larvol Delta - First-Patient-Dosed-in-the-US-in-Avactas-AVA6000-Phase-1-Clinical-Study

pro-doxorubicin (AVA6000) - Avacta

https://www.businesswire.com/news/home/20230427005500/en/First-Patient-Dosed-in-the-US-in-Avacta%E2%80%99s-AVA6000-Phase-1-Clinical-Study

Apr 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next